Publisher： Bentham Science Publishers
E-ISSN： 1873-4286|20|17|2934-2947
ISSN： 1381-6128
Source： Current Pharmaceutical Design, Vol.20, Iss.17, 2014-05, pp. : 2934-2947
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
TGF-Beta Signaling Manipulation as Potential Therapy for IBD
Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. :
Access to resources
Recommend
TGF Beta Inhibition for Cancer Therapy
Current Cancer Drug Targets, Vol. 6, Iss. 7, 2006-11 ,pp. :
Targeting TGF-β signaling in cancer
By Katz Lior H
Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. :
TGF-Beta: a Master Switch in Tumor Immunity
Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. :